How Kaposi's sarcoma-associated herpesvirus stably transforms peripheral B cells towards lymphomagenesis.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
13 08 2019
Historique:
pubmed: 1 8 2019
medline: 26 3 2020
entrez: 1 8 2019
Statut: ppublish

Résumé

Primary effusion lymphomas (PELs) are causally associated with Kaposi's sarcoma-associated herpesvirus (KSHV) and 86% of PELs are coinfected with Epstein-Barr virus (EBV). Understanding how PELs develop has been impaired by the difficulty of infecting B cells with KSHV in vitro, and the inability of KSHV to transform them. We show that EBV supports an optimal coinfection of 2.5% of peripheral B cells by KSHV. This coinfection requires 1 or more transforming genes of EBV but not entry into KSHV's lytic cycle. We demonstrate that dually infected B cells are stably transformed in vitro and show that while both viruses can be maintained, different cells exhibit distinct, transformed properties. Transformed cells that grow to predominate in a culture express increased levels of most KSHV genes and differentially express a subset of cellular genes, as do bona fide PEL cells. These dually infected peripheral B cells are thus both stably transformed and allow in vitro molecular dissection of early steps in the progression to lymphomagenesis.

Identifiants

pubmed: 31363046
pii: 1905025116
doi: 10.1073/pnas.1905025116
pmc: PMC6697783
doi:

Substances chimiques

CD40 Ligand 147205-72-9
Green Fluorescent Proteins 147336-22-9
Interleukin-4 207137-56-2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

16519-16528

Subventions

Organisme : NCI NIH HHS
ID : P01 CA022443
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA014520
Pays : United States
Organisme : NIH HHS
ID : S10 OD018202
Pays : United States

Informations de copyright

Copyright © 2019 the Author(s). Published by PNAS.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Blood. 2005 Mar 15;105(6):2510-8
pubmed: 15572586
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
J Exp Med. 2004 Apr 5;199(7):993-1003
pubmed: 15067035
J Virol. 1998 Jun;72(6):5182-8
pubmed: 9573290
Science. 2002 Nov 15;298(5597):1432-5
pubmed: 12434062
Curr Top Microbiol Immunol. 2008;325:101-15
pubmed: 18637502
J Exp Med. 1995 Nov 1;182(5):1265-73
pubmed: 7595197
Lancet. 1997 Mar 1;349(9052):609-11
pubmed: 9057733
J Virol. 2008 May;82(10):4793-806
pubmed: 18337571
Proc Natl Acad Sci U S A. 1983 May;80(9):2762-6
pubmed: 6302703
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Blood. 1996 Jul 15;88(2):645-56
pubmed: 8695812
Nat Med. 1995 Dec;1(12):1274-8
pubmed: 7489408
Blood. 2009 May 28;113(22):5660-8
pubmed: 19324905
EMBO J. 2007 Oct 3;26(19):4252-62
pubmed: 17853891
J Virol. 2001 Aug;75(16):7517-27
pubmed: 11462024
N Engl J Med. 1995 May 4;332(18):1181-5
pubmed: 7700310
AIDS. 2000 Jun 16;14(9):1123-33
pubmed: 10894276
Am J Pathol. 1998 Nov;153(5):1609-14
pubmed: 9811353
J Virol. 2003 Jun;77(11):6474-81
pubmed: 12743304
J Cell Biol. 2017 Sep 4;216(9):2745-2758
pubmed: 28696226
J Virol. 2001 Dec;75(23):11583-93
pubmed: 11689640
J Clin Invest. 2011 Mar;121(3):1130-40
pubmed: 21339648
Blood. 1995 Aug 15;86(4):1276-80
pubmed: 7632932
Proc Natl Acad Sci U S A. 2018 Nov 27;115(48):E11379-E11387
pubmed: 30429324
Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8245-50
pubmed: 9653172
Cancer Res. 2008 Sep 1;68(17):6963-8
pubmed: 18757410
Genome Biol. 2014;15(12):550
pubmed: 25516281
Appl Environ Microbiol. 1992 Aug;58(8):2606-15
pubmed: 1381174
Nature. 1989 Aug 3;340(6232):393-7
pubmed: 2547164
Bioinformatics. 2019 Jun 1;35(12):2084-2092
pubmed: 30395178
Blood. 2003 May 15;101(10):4115-21
pubmed: 12531789
Cell Host Microbe. 2017 Jul 12;22(1):61-73.e7
pubmed: 28704654
Blood. 2000 Oct 1;96(7):2537-42
pubmed: 11001908
J Virol Methods. 2011 Jun;174(1-2):12-21
pubmed: 21419799
Oncologist. 2007 May;12(5):569-76
pubmed: 17522245
J Virol. 1998 Oct;72(10):8309-15
pubmed: 9733875
Proc Natl Acad Sci U S A. 2012 May 22;109(21):E1396-404
pubmed: 22543160
Front Microbiol. 2012 Jan 20;3:6
pubmed: 22319516
Nat Methods. 2015 May;12(5):380-1
pubmed: 25924071
J Exp Med. 1996 Jul 1;184(1):283-8
pubmed: 8691144
Virology. 1982 Oct 30;122(2):431-43
pubmed: 6293180
Proc Natl Acad Sci U S A. 2019 Aug 13;116(33):16519-16528
pubmed: 31363046
Anticancer Res. 2011 Jul;31(7):2467-76
pubmed: 21873161
J Clin Invest. 2011 Feb;121(2):752-68
pubmed: 21245574
J Exp Med. 1996 May 1;183(5):2385-90
pubmed: 8642350
Proc Natl Acad Sci U S A. 1974 Oct;71(10):4006-10
pubmed: 4372601
Viruses. 2014 Oct 23;6(10):4024-46
pubmed: 25341665
J Virol. 2016 Mar 28;90(8):3849-3859
pubmed: 26819313
PLoS One. 2008 Jan 23;3(1):e1464
pubmed: 18213373
Lancet. 1995 Mar 25;345(8952):761-2
pubmed: 7891488
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Science. 1995 Apr 28;268(5210):582-3
pubmed: 7725108
EMBO J. 2002 Mar 1;21(5):954-65
pubmed: 11867523
Nat Genet. 2003 Jul;34(3):267-73
pubmed: 12808457
PLoS Pathog. 2018 Apr 16;14(4):e1006967
pubmed: 29659614
J Virol. 2004 Jun;78(12):6389-98
pubmed: 15163732
J Virol. 2012 Sep;86(18):9696-707
pubmed: 22740393
J Gen Virol. 1977 Jul;36(1):59-74
pubmed: 886304
J Virol Methods. 2008 Dec;154(1-2):160-6
pubmed: 18755221
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Semin Cancer Biol. 1999 Jun;9(3):165-74
pubmed: 10343068
Blood. 2008 Jan 1;111(1):320-7
pubmed: 17890449
Blood. 1999 Oct 15;94(8):2871-9
pubmed: 10515891
Leukemia. 1999 Jul;13(7):1093-9
pubmed: 10400426
J Biomed Biotechnol. 2012;2012:357060
pubmed: 22675249
Adv Cancer Res. 2010;108:1-19
pubmed: 21034964
Blood. 2011 Feb 10;117(6):1977-85
pubmed: 21088132
J Gen Virol. 1972 Nov;17(2):233-6
pubmed: 4344316
Pathogens. 2017 Mar 19;6(1):
pubmed: 28335496
J Virol. 1977 Sep;23(3):503-8
pubmed: 197258
J Virol. 2012 Sep;86(18):9708-20
pubmed: 22740391
Virology. 2011 Apr 25;413(1):1-11
pubmed: 21353276
Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14862-7
pubmed: 8962146
Science. 1994 Dec 16;266(5192):1865-9
pubmed: 7997879

Auteurs

Aurélia Faure (A)

McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI 53705.

Mitch Hayes (M)

McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI 53705.

Bill Sugden (B)

McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI 53705 sugden@oncology.wisc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH